Celltech

Celltech

File:Celltechlogo.PNG

The logo of Celltech

Celltech was a pioneering biotechnology company based in the United Kingdom. Founded in 1980, it was one of the first biotechnology companies in Europe and played a significant role in the development of the biotechnology industry in the UK.

History

Celltech was established in 1980 by a group of scientists and entrepreneurs who recognized the potential of biotechnology to transform medicine and healthcare. The company initially focused on the development of monoclonal antibodies and other innovative therapeutic approaches.

In the 1990s, Celltech expanded its research and development efforts, entering into collaborations with major pharmaceutical companies to advance its drug discovery programs. The company became known for its work in immunology and oncology, developing several promising drug candidates.

Acquisitions and Mergers

In 1999, Celltech acquired Chiroscience, another UK-based biotechnology company, which helped to strengthen its position in the industry. This acquisition was part of a broader strategy to expand its capabilities and pipeline.

In 2004, Celltech itself was acquired by the Belgian pharmaceutical company UCB. This acquisition marked the end of Celltech as an independent entity, but its legacy continued as part of UCB's global operations.

Contributions to Biotechnology

Celltech made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. The company's research efforts led to the discovery of several important therapeutic agents that have been used in the treatment of various diseases.

The company's work in biopharmaceuticals helped to establish the UK as a leader in the biotechnology sector, paving the way for future innovations and developments in the field.

Legacy

Although Celltech no longer exists as an independent company, its impact on the biotechnology industry is still felt today. The company's pioneering efforts in drug discovery and development have influenced many of the current practices and technologies used in the field.

Related pages

• Biotechnology
• Monoclonal antibody
• UCB (company)
• Pharmaceutical industry